NORMAL SALINE 0.9% W/V (IV) INFUSION 500ML

Indications

Approved Uses

Parenteral replacement of extracellular fluid and sodium/chloride (e.g., dehydration/hypovolemia with sodium/chloride depletion) and as a vehicle/diluent for IV drug administration; may also be used for priming extracorporeal circuits (e.g., hemodialysis) per institutional protocol.

Off-Label Uses

For this IV infusion product, off-label uses may include use as a nebulization diluent and for flushing/maintaining IV line patency (institution-dependent); wound/nasal irrigation is typically performed with specifically labeled irrigation saline products rather than IV infusion bottles.

Dosage & Administration

Dosing by Condition

Dose, rate, and duration are individualized based on indication (resuscitation vs maintenance vs diluent), age/weight, hemodynamics, and labs; administer per physician order and institutional protocols rather than fixed volumes.

Initial Dose

500-1000 ml IV infused over 1-4 hours depending on clinical urgency

Maintenance Dose

1500-2500 ml per 24 hours adjusted to clinical response and fluid balance

Maximum Dose

No fixed maximum dose; volume/rate are individualized based on indication (e.g., resuscitation vs maintenance), hemodynamics, urine output, and electrolyte/acid-base monitoring.

Children's Dosage

Neonates and children: 20 ml/kg IV bolus for resuscitation, repeated as needed; maintenance calculated by weight using Holliday-Segar method (100 ml/kg for first 10 kg, 50 ml/kg for next 10 kg, 20 ml/kg thereafter per 24 hours)

Dose Adjustment Notes

Use with caution and consider lower volumes/rates in patients at risk of sodium/water retention (e.g., heart failure, significant renal impairment, cirrhosis); tailor therapy to clinical status and monitor fluid balance, electrolytes, and acid-base balance.

How to Take

For intravenous infusion (parenteral use) using aseptic technique and a sterile IV administration set; inspect for clarity/particulates and container integrity before use; do not use if cloudy, discolored, leaking, or container is damaged; administer at the prescribed rate and volume; single-use container-discard any unused portion.

How to Prepare

Ready-to-use IV solution; no reconstitution required. Inspect container/solution for leaks, particulate matter, or discoloration; use aseptic technique. If used as a diluent/vehicle for other IV medications, confirm compatibility/stability and follow the specific product’s dilution instructions.

Side Effects

Common Side Effects

Infusion site reactions (pain, irritation, erythema, phlebitis/thrombosis) and, with excessive or rapid administration, fluid overload/edema and electrolyte/acid-base disturbances such as hypernatremia and hyperchloremic metabolic acidosis.

Side Effect Frequency

Frequencies are generally not well quantified for IV 0.9% sodium chloride; report as 'frequency not known' with key risks: infusion-site reactions/phlebitis, fluid overload (including pulmonary edema), hypernatremia, hyperchloremia and hyperchloremic metabolic acidosis (especially with large volumes), and hypersensitivity reactions (rare).

Safety & Warnings

Contraindications

No absolute contraindication in most labeling; avoid/use only if clearly indicated in hypernatremia or hyperchloremia and in severe fluid-overload states (e.g., decompensated heart failure, severe renal failure/oliguria-anuria, severe edema/ascites) unless under close monitoring.

Warnings & Precautions

Monitor fluid balance, electrolytes, and acid-base status during therapy (especially large/prolonged infusions); use caution in heart failure, renal impairment, cirrhosis/ascites, hypertension, edema, and pre-eclampsia; large volumes can cause hyperchloremic metabolic acidosis; inspect solution/container integrity and use appropriate IV administration precautions.

Age Restriction

No specific age restriction; can be used in all age groups (including neonates/children) with weight- and clinical status-based dosing and monitoring.

Drug Interactions

Drug Interactions

Corticosteroids/corticotropin: additive sodium and fluid retention; Lithium: increased sodium load can increase renal lithium clearance and lower lithium levels (changes in sodium/fluid balance can alter lithium concentrations).

Interaction Severity

MODERATE: Corticosteroids/corticotropin (additive sodium and water retention). MODERATE: Lithium (changes in sodium balance can alter lithium renal clearance and serum levels-often decreased with higher sodium/IV saline, increased with sodium depletion).

Food Interaction

No clinically relevant food interactions (not applicable for IV administration).

Special Populations

Children

Neonates and children: 20 ml/kg IV bolus for resuscitation, repeated as needed; maintenance calculated by weight using Holliday-Segar method (100 ml/kg for first 10 kg, 50 ml/kg for next 10 kg, 20 ml/kg thereafter per 24 hours)

Kidney Impairment

No specific CrCl-based adjustment; use great caution in renal impairment/oliguria-anuria-reduce volume/rate and monitor for sodium retention, edema, and electrolyte/acid-base changes.

Storage & Patient Advice

Preparation Instructions

Ready-to-use IV solution; no reconstitution required. Inspect container/solution for leaks, particulate matter, or discoloration; use aseptic technique. If used as a diluent/vehicle for other IV medications, confirm compatibility/stability and follow the specific product’s dilution instructions.

Missed Dose

Not applicable-administered and titrated by healthcare professionals; if an infusion is interrupted, restart/adjust per clinical status and prescriber order.

Stopping the Medicine

Administered and discontinued by healthcare professionals; stop when the clinical indication is resolved or if signs of fluid/electrolyte overload occur, per prescriber protocol.

Overdose

Overdose/excess administration may cause fluid overload (peripheral/pulmonary edema, hypertension), hypernatremia, hyperchloremia, and hyperchloremic metabolic acidosis; manage by stopping infusion, supportive care, diuretics if appropriate, and correcting electrolytes-dialysis may be required in severe renal failure.

Patient Counseling

Administered IV by healthcare professionals; patients should promptly report infusion-site pain/redness/swelling, shortness of breath, facial/lip swelling or rash (hypersensitivity), or symptoms of fluid overload (rapid weight gain, edema, worsening breathlessness). Inform the care team of heart failure, renal impairment, liver disease/cirrhosis, hypertension, or any fluid/salt-restricted diet before infusion.

Monitoring Requirements

Monitor fluid balance (I&O, weight), vital signs/hemodynamics, and serum electrolytes (especially sodium/chloride) with acid-base status during large-volume or prolonged therapy; watch for signs of fluid overload.

Pharmacology

Mechanism of Action

Provides isotonic water and sodium/chloride to expand extracellular fluid volume and replenish electrolytes, helping maintain osmotic pressure and fluid distribution without causing major transcellular water shifts when given appropriately.

Onset of Action

Immediate upon IV administration.

Duration of Effect

Hemodynamic/volume-expanding effect is transient: only a fraction remains intravascular after infusion, with most distributing to the extracellular space within ~30-60 minutes; clinical effect persists while infusion continues and depends on ongoing losses and renal handling.

Half-Life

Not meaningfully defined/clinically applicable; sodium and chloride do not have a fixed elimination half-life and their kinetics depend on distribution and renal/homeostatic regulation (e.g., volume status, RAAS/ADH, kidney function).

Bioavailability

100% (intravenous administration)

Metabolism

Not metabolized; sodium and chloride are endogenous ions regulated by physiologic mechanisms.

Excretion

Primarily renal excretion/regulation (kidneys) of sodium and chloride; minor losses can occur via sweat and gastrointestinal secretions.

Protein Binding

Not protein-bound (not applicable).

Product Information

Available Dosage Forms

Solution for infusion (parenteral) in containers such as bottles/bags; separate products may exist as irrigation solutions, but this SFDA-registered product is an IV infusion solution in a bottle.

Composition per Dose

Each 100 mL: Sodium Chloride 0.9 g (equivalent to Na⁺ 15.4 mEq and Cl⁻ 15.4 mEq) in water for injection. Each 500 mL: Sodium Chloride 4.5 g (equivalent to Na⁺ 77 mEq and Cl⁻ 77 mEq) in water for injection

Generic Availability

Yes

OTC Alternatives

No OTC alternative

Primary Use

Intravenous isotonic fluid used for extracellular fluid replacement, electrolyte replenishment, and as a vehicle for IV drug administration

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.